As we get close to the end of our campaign here on Republic.co, it’s been an exciting week here at CNS Pharmaceuticals. Our campaign has nearly raised $600K which is fantastic. The power of the crowd just amazes me. But, the best part for me has been having our entire team here in Houston, near the MD Anderson Cancer Center, where Berubicin was developed. We’ve been busy meeting and planning the next phase of development for our lead drug and there was a lot of intellectual firepower in the room!
Going around the table from the lower left in the photo below you’ll see Waldemar Priebe, Ph.D., the developer of Berubicin and our founder. Seated to the left of Dr. Priebe, in order, are Sigmund Hsu, M.D., one of our amazing clinical advisors, Sandra Silberman, M.D., Ph.D., our Chief Medical Officer, and Matt Lourie, C.P.A., our Acting CFO. On the right side of the table, from left to right, you’ll see me, Cavas Pavri, our outside counsel, Don Picker, Ph.D., one of our board members, and Anna Pawliczek, Ph.D., our Clinical Coordinator.
Combining the great success we've had here on Republic.co, and the funds we will continue to raise in the near future, with the world-class team we've assembled, we’re all excited to continue to fight this terrible disease.
One final note: In a few short days remaining in our campaign, please remember to tell your friends and family to join us! After all, you've done the due diligence for them! And, Republic.co recently informed us that their credit card limit has increased from $2000 to $5000 so some of you may want to consider putting more capital to work here!
Thank you all once again for your support.